Aptose Biosciences Inc. financial data

Symbol
APTOF on OTC
Location
66 Wellington Street West, Suite 5300, Td Bank Tower Box 48, Toronto, Ontario, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 87.6 % -0.93%
Debt-to-equity -165 % +62.5%
Return On Equity 169 % -83.4%
Return On Assets -261 % +13%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.55M shares -86.9%
Common Stock, Shares, Outstanding 2.55M shares -86.9%
Entity Public Float 22.1M USD -25.4%
Common Stock, Value, Issued 460M USD +1.65%
Weighted Average Number of Shares Outstanding, Basic 2.55M shares +316%
Weighted Average Number of Shares Outstanding, Diluted 2.55M shares +316%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 7.41M USD -65%
General and Administrative Expense 12.1M USD +4.78%
Nonoperating Income (Expense) 188K USD -52.6%
Net Income (Loss) Attributable to Parent -19.3M USD +46.1%
Earnings Per Share, Basic 2 USD/shares +82.3%
Earnings Per Share, Diluted 2 USD/shares +82.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 613K USD -92.3%
Cash, Cash Equivalents, and Short-term Investments 1.6M USD -80%
Other Assets, Current 127K USD -90.7%
Assets, Current 3.78M USD -63.1%
Property, Plant and Equipment, Net 8K USD -73.3%
Operating Lease, Right-of-Use Asset 277K USD -58.3%
Other Assets, Noncurrent 2.28M USD
Assets 6.34M USD -42%
Accounts Payable, Current 1.46M USD -20.4%
Employee-related Liabilities, Current 2.6M USD +197%
Accrued Liabilities, Current 4.8M USD -36%
Liabilities, Current 7.08M USD -27.5%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 25.8M USD +28.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.32M USD 0%
Retained Earnings (Accumulated Deficit) -559M USD -3.58%
Stockholders' Equity Attributable to Parent -19.5M USD -113%
Liabilities and Equity 6.34M USD -42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -27M USD +40%
Net Cash Provided by (Used in) Financing Activities 22.4M USD +19.7%
Net Cash Provided by (Used in) Investing Activities 2.01M USD -81.6%
Common Stock, Shares, Issued 2.55M shares -86.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -2.6M USD +83.1%
Deferred Tax Assets, Valuation Allowance 98M USD +7.38%
Deferred Tax Assets, Gross 98M USD +7.38%
Operating Lease, Liability 305K USD -57.7%
Depreciation 3K USD -81.3%
Payments to Acquire Property, Plant, and Equipment 29K USD +20.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.1M USD +47.6%
Lessee, Operating Lease, Liability, to be Paid 314K USD -59.3%
Property, Plant and Equipment, Gross 544K USD -32.1%
Operating Lease, Liability, Current 305K USD -26.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 197K USD -57.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 197K USD -57.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 198K USD
Deferred Tax Assets, Operating Loss Carryforwards 80M USD +8.7%
Operating Lease, Payments 457K USD -0.87%
Additional Paid in Capital 83.8M USD +1.83%
Depreciation, Depletion and Amortization 46K USD -53.1%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 491K USD -65.3%